MedTrace Logo

Outcomes From Treatment Liver and Bile Duct Diseases

NCT04637243 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2024-03-27

No results posted yet for this study

Summary

It is reported in the literature that the treatment of any liver and bile duct disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with adenocarcinoma continue to be diagnosed at an advanced stage with medical and surgical options that are improving in terms of outcome measurements but with much more room for improvement. Our goal is to continue to review our treatment outcomes to further improve overall survival, overall symptom control, mortality and morbidity.

The main aim of this study is to evaluate and compare the outcomes from our multiple treatments of benign or malignant liver and bile duct diseases.

Conditions

  • Benign or Malignant Liver and Bile Duct Disease

Interventions

OTHER

Treatment of Benign or Malignant Liver and Bile Duct Diseases

Available treatment of Benign or Malignant Liver and Bile Duct Diseases

Sponsors & Collaborators

  • Methodist Health System

    lead OTHER

Principal Investigators

  • Dhiresh Jeyarajah, M.D. · Trinity Surgical Consultants, Methodist Richardson Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-09
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04637243 on ClinicalTrials.gov